Metagenomi Therapeutics, Inc. Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Period Increase Decrease
Financial Statements › Balance Sheet › Assets › Credit Losses › Allowance for Credit Loss
us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease · last filed 2026-03-05
- Metagenomi Therapeutics, Inc. debt securities available for sale excluding accrued interest allowance for credit loss period increase decrease for fiscal 2025 was $0.00.
| Period end | Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Period Increase Decrease 12 month |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-05 |